constituents of tobacco on estrogen production in human chonocarcinoma cells and term placental microsomes.
Introduction
Recent epidemiologic evidence suggests that women who smoke have decreased endogenous estrogens (1) . For example, endometrial cancer, which is thought to be an estrogen-dependent process, occurs less frequently in women who smoke than in nonsmokers (2) . MacMahon et al. (3) have reported that in normally cycling women who smoke, urinary estrogens in the luteal phase of the cycle are lower than in nonsmokers. In pregnancy, women who smoke have lower estrogens than nonsmokers (4) . Circumstantial evidence that women who smoke have disturbed endogenous estrogen production and/or metabolism is provided by epidemiologic studies which demonstrate that women who smoke have an earlier age of menopause (5, 6) and are at greater risk for postmenopausal osteoporosis (7, 8) than nonsmokers. To explore the possible link between cigarette smoking and decreased endogenous estrogens, we have examined the effects of tomycin. Under these conditions, the cell number doubled every 2 d.
Replicate cultures for experimentation were obtained by trypsinizing the cells in the feeder flasks and replating these cells at a density of -2.0 x 105 cells/well in a multiwell plate with a well diameter of 16 mm. The cells were allowed to explant in the new wells for 16 h before experimentation. To begin all experiments the culture media were replaced with RPMI 1640 without serum, and the experimental agents were then added in a vehicle consisting of RPMI 1640. At the end of the experimental culture period the media were frozen, and the cells trypsinized and counted in a hemocytometer.
Assessment ofestrogen production in Jar choriocarcinoma cell cultures
The media was extracted two times with 7 vol of ether. The ether extract was dried under a stream of N2, redissolved in isooctane, and applied to celite chromatography columns. Using isooctane and ethyl acetate as the mobile phase, progesterone, androstenedione, dihydrotestosterone, testosterone, estrone, and estradiol were sequentially eluted from the column (10, 1) . Steroids were then measured using radioimmunoassays employing specific antibodies. Nicotine, cotinine, and anabasine did not interact with the antibodies used in the radioimmunoassays. Tritiated steroids were added to the samples just before ether extraction to assess recovery.
Placental microsomal preparations. Human term placentas were obtained at cesarean section. Placental microsomes were prepared as previously described (12) . Microsomal protein concentration was measured using the method of Bradford ( 13).
Assessment ofaromatase activity in human term placental microsomes Aromatase activity was assessed in the placental microsomes by measuring the amount of 3H2O formed due to the release of 3H during the aromatization of [11,,2,B-3H]testosterone (14). The reaction mixture consisted of varying concentrations of [1I ,2,3-3H]testosterone (48.3 Ci/mmol, sp act), 0.15 M NaCl, 10 mM P04 buffer, pH 7.4, at 37°C, 500MuM NADPH, 50 mM glucose-6-phosphate, and 10 U/ml of glucose-6-phosphate dehydrogenase, in a final volume of 0.5 ml. The reaction was started by adding the placental microsomes. The reactions were carried out in room air at 37°C in triplicate for 3 and 6 min to assess linearity of reaction velocity. The reaction was terminated by adding 0.6 ml of dextran-coated charcoal. The charcoal-treated samples were incubated for 30 min and then centrifuged at 3,000 g for 10 min. The quantity of 3H20 in the aqueous supernatant was assessed by liquid scintillation counting.
Assessment of 1 7f-hydroxysteroid dehydrogenase activity in human term placental microsomes 17#-Hydroxysteroid dehydrogenase was assayed as previously described (15) . In brief, the reaction mixture consisted of 0.15 M KCI, 50 mM Tris, pH 7.4, at 37°C, 500 AM NADPH, 50 mM glucose-6-phosphate, 5 U glucose-6-phosphate dehydrogenase, 5 mM MgC12, -0.5 MCi of [6,7-3H] estrone (45 Ci/mmol, sp act), 10 ,g placental microsomal protein, and various concentrations of nicotine in a final volume of 0.5 ml. The reaction mixture and the microsomal protein were preincubated separately at 37°C. The reaction was started by the addition of 0.1 ml of microsomal protein to the reaction mixture. Samples were incubated in duplicate for 3 and 6 min to verify linearity of reaction velocity. After incubation, the reaction was stopped by the addition of0.5 ml methanol. An aliquot of the reaction mixture was applied to silica gel thin-layer plates and product (estradiol) and substrate (estrone) were separated using a solvent system ofether/hexane (3:1, vol/vol). The product and substrate were eluted from the gel and the radioactivity measured by liquid scintillation spectrometry. The authenticity of the product was established by high performance liquid chromatography.
Preparation ofsmoke solutions
Whole, aqueous cigarette smoke solutions were prepared as previously described (16). In brief, every minute, 35 ml oftobacco smoke was drawn into a reservoir in a 2-s puff, until the cigarette butt was 5 cm in length. The smoke from two standard cigarettes was bubbled into 2 ml of 0.01 M phosphate-buffered saline (PBS), pH 7.40. After the introduction of the smoke into the buffer the pH remained at 7.40. The aqueous solution was then passed through a 0.22-MM filter to remove small particles.
In some experiments, the aqueous extracts were dialyzed against three changes of200 vol PBS at 4°C using Spectra-Por 6 dialysis tubing (1,000 mol wt exclusion; Spectrum Medical Industries, Los Angeles, CA).
Spectral determinations
Spectral determinations were made, as previously described (17), using a DW-2 UV-visible spectrophotometer (American Instrument Co., Silver Spring, MD). Cytochrome P-450 concentrations were measured by the method of Estabrook (18) using an extinction coefficient of 100 mM' I -cm-' for the absorption difference at 450 nm minus 500 nm. To determine the spectral changes caused by the addition of experimental compounds to the microsomal preparations, 2 ml of a microsomal suspension was divided between sample and reference cuvettes, and a baseline ofequal light absorbance was obtained. The experimental compound, dissolved in ethanol, was added to the sample cuvette and an equal concentration ofethanol was added to the reference cuvette. The ethanol concentration in the cuvettes never exceeded 1.0% (vol/vol [6,7-3H] estradiol to 2 X I05 choriocarcinoma cells for 24 h resulted in the conversion of < 15% of the progesterone and <10% of the estradiol to other metabolites as determined by high performance liquid chromatography. Using radioactive progesterone and estradiol, partitioning experiments demonstrated that 95% of these two steroids were present in the culture medium and <5% in the explanted cells. These results suggest that progesterone and estradiol accumulation in the media correlate well with production.
Addition ofandrostenedione to the choriocarcinoma cultures resulted in the appearance ofboth estradiol and estrone, but not testosterone or dihydrotestosterone. For example, the addition of 18 nM androstenedione to 200,000 choriocarcinoma cells for 18 h resulted in the detection of 12.6 nM estradiol, 1.26 nM estrone, 25.3 nM progesterone, and <0.2 nM testosterone and dihydrotestosterone in the media at the end of the incubation (Table I) . In all experiments the accumulation ofestradiol always exceeded the accumulation of estrone, and the ratio of estradiol to estrone was in the range of 6:1-10:1.
Effects ofaqueous extracts ofcigarette smoke on estrogen accumulation in choriocarcinoma cell cultures Aqueous extracts ofsmoke inhibited androstenedione conversion to estradiol in a dose-dependent manner (Fig. I A) . 50% inhibition ofaromatase was observed at a smoke extract dose between 1 and 5 Ml (1 Ml of aqueous smoke solution represents 0.1% of a cigarette equivalent). At the doses used in this study, aqueous extracts of cigarette smoke did not inhibit progesterone accumulation or the cell number present in the culture. The PBS vehicle, in doses up to 30 ,l, did not affect estradiol accumulation. Dialyzed smoke preparations (1,000 mol wt effective pore size) inhibited androstenedione conversion to estradiol in a dosedependent manner (Fig. 1 B) . At the highest dose tested, 25 ,l, aromatization was inhibited by 40%. Therefore, -10% of the aromatase inhibitory activity of aqueous extracts of cigarette smoke was present in the > I,000-mol-wt fraction. Removal of the aqueous extract ofcigarette smoke from the culture medium resulted in the complete reversal ofthe inhibition of aromatase, and the return of normal rates of aromatization.
Effects ofnicotine, cotinine, and anabasine on estrogen accumulation in choriocarcinoma cell cultures The addition of nicotine, cotinine, or anabasine to the choriocarcinoma cell cultures inhibited estradiol accumulation in the media (Fig. 2) . The addition of nicotine to the choriocarcinoma cell cultures resulted in the inhibition of both estradiol and estrone accumulation and a corresponding increase in unmetabolized androstenedione (Table I) . At all nicotine concentrations tested, the estradiol to estrone ratio exceeded 6 (Fig.  3) . Nicotine inhibition ofestradiol accumulation was linear over the first 8 h of incubation (Fig. 3 ). In the choriocarcinoma cell cultures, the concentration of androstenedione present in the culture medium strongly influenced the degree of inhibition of estradiol accumulation produced by nicotine. For example, when the culture medium contained 11 nM androstenedione, 30,M nicotine produced an -50% inhibition of estradiol accumulation. In contrast, when the culture medium contained 73 1tM androstenedione, 30 ,M nicotine produced no inhibition of estradiol accumulation (Fig. 4) . Figure 2 . Effects of nicotine, cotinine, and anabasine on estrogen and progesterone accumulation in choriocarcinoma cell cultures. 2.0 X l0 choriocarcinoma cells were cultured for 8 h in serum-free RPMI 1640 with 11 nM androstenedione and various concentrations of the experimental agents. At the end of the incubation, the media was assayed for progesterone, estradiol, and estrone. The estrone accumulation was < 17% of the estradiol accumulation at all points. Mean±SEM, n = 4 for each group. *P < 0.01; **P < 0.0001 compared with vehicle control.
Nicotine, Cotinine, and Anabasine Inhibit Aromatase 1729 As noted above, nicotine, cotinine, and anabasine all inhibited estradiol accumulation in choriocarcinoma cells at micromolar concentrations. In contrast, at concentrations in the range of 1 mM, carbamylcholine, succinylcholine, hexamethonium, and decamethonium did not inhibit estradiol accumulation (Table III) Nicotine (M) control. from 10 women). These values are similar to those previously reported (17) .
In all preparations of placental microsomes examined, nicotine, cotinine, and anabasine inhibited the conversion of [ 1(,2,3- 3H]testosterone to 3H20. Dixon plot analysis demonstrated that nicotine, cotinine, and anabasine inhibition of aromatase was competitive with respect to the testosterone substrate (Figs. 5  and 6 ). The effects of nicotine on aromatase in placental microsomes was assessed in tissue obtained from five women. In these five separate experiments the apparent enzymatic inhibition constants (K,)' for nicotine inhibition of aromatization were 15, 17, 25, 37, and 73 ,M (33±10.6 MuM, mean±SEM) (Fig. 5) . The effects of cotinine on aromatase in placental microsomes was assessed in tissue obtained from three women. In these three separate experiments the Kis for cotinine inhibition of aromatization were 15, 36, and 47 MuM (32.7±9.38 MM, mean±SEM) (Fig. 6) . The effects of anabasine on aromatase in placental microsomes was assessed in tissue obtained from two women. In these two experiments the apparent Kis for anabasine inhibition of aromatase were 2 and 3 MM.
In contrast to nicotine, cotinine, and anabasine, the cholinergic agents-hexamethonium, decamethonium, acetylcholine, succinylcholine, carbamylcholine, and muscarine-did not inhibit aromatase in the placental microsomes (Table IV) . Lobeline, at concentrations of 100 MM, produced a 30% inhibition of placental microsomal aromatase.
Effects ofnicotine on 1 7f-hydroxysteroid dehydrogenase activity in term placental microsomes Nicotine, at concentrations as high as 100 MM, did not significantly alter placental microsomal 17j3-hydroxysteroid dehydrogenase activity (Table V) .
Spectral analysis ofnicotine interaction with placental microsomal cytochrome P-450 In the preparations of placental microsomes, the concentration of cytochrome P-450 ranged from 0.04 to 0.055 nmol/mg mi- crosomal protein. Addition of nicotine to placental microsomal preparations elicited a type II cytochrome P-450 difference spectrum with a broad Soret minimum between 390 and 400 nm and a Soret maximum at 428 nm (Fig. 7) . 
Discussion
In both the choriocarcinoma cell cultures and placental microsomes, micromolar concentrations of nicotine, cotinine, and anabasine inhibited estrogen formation. It is unlikely that the nicotine inhibition of estradiol accumulation observed in the choriocarcinoma cell cultures is due to a "nonspecific" detrimental effect on cell function. Evidence to suggest that nicotine inhibition ofestradiol accumulation was due to a highly specific mechanism includes the following observations: (a) No change in progesterone accumulation or cell number was observed at nicotine concentrations that produced 50% inhibition ofestradiol accumulation; (b) The nicotine inhibition of estradiol accumulation was completely reversible by removing the nicotine However, the experiments examining the effects of nicotine on aromatase in term placental microsomes suggests that nicotine directly inhibits the choriocarcinoma cell aromatase enzyme system.
In term placental microsomes, micromolar concentrations of nicotine, cotinine, and anabasine competitively inhibited the aromatization of testosterone. This finding, in conjunction with the spectral evidence that nicotine interacted directly with placental microsomal cytochrome P-450, suggests that nicotine may inhibit placental aromatase by reversibly altering the function of the active site(s) of the cytochrome P-450 component of the aromatase enzyme system.
Aminoglutethimide is an inhibitor of aromatase that is used clinically in the hormonal therapy of metastatic breast cancer. In placental microsomal preparations, aminoglutethimide competitively inhibits the aromatization of testosterone with an apparent Ki of 14 ,uM (20) . The addition of aminoglutethimide to preparations ofplacental microsomes elicits a type II cytochrome P450 binding spectrum (20) . Given these functional similarities between aminoglutethimide and nicotine, it is of interest to note that nicotine, cotinine, anabasine, and aminoglutethimide all share substantial chemical structural similarities. In ,uM (27, 28) . In pregnant women the cotinine concentration in the fetal circulation is 2-4-fold higher than the cotinine concentration in the maternal circulation (4 If the granulosa cell and placental aromatase are similar, then the in vitro observation that nicotine and cotinine "competitively" inhibit placental aromatase could explain these findings. In the follicular phase ofthe menstrual cycle, the ovarian follicle that gains dominance produces the majority of circulating estrogens (29). A characteristic of the dominant ovarian follicle is that a restricted follicular microenvironment is present. The follicular microenvironment consists of those elements on the avascular side ofthe follicular basement membrane: (a) granulosa cells, (b) antral fluid, and (c) oocyte. In the follicular phase of the menstrual cycle, the circulating androstenedione concentration is -5 nM. However, the intrafollicular concentration of androstenedione is -500 times greater, 2.5 ,M (30) . The aromatase enzyme system in the granulosa cell is probably exposed to the intrafollicular concentration of androstenedione, 2.5 ,uM. If the intrafollicular concentration of nicotine plus cotinine were 5 gM, the ratio of nicotine plus cotinine to androstenedione would be 2:1. This ratio is too low to produce significant inhibition. In contrast, in the luteal phase of the menstrual cycle, the basement membrane of the dominant follicle is disrupted, and the follicular microenvironment is lost. The aromatase enzyme system in the cells comprising the corpus luteum is probably exposed to an androstenedione concentration similar to that in the circulation, 5 nM. If the corpus luteum is exposed to a nicotine plus cotinine concentration of 5 gM, then the ratio of nicotine plus cotinine to androstenedione would be 1,000:1. This high ratio could produce significant inhibition of the aromatase system and a decrease in estrogen production.
In postmenopausal women, circulating androstenedione concentrations less than 2 nM are common (18). Therefore, in postmenopausal women, the ratio of nicotine plus cotinine to androstenedione at the peripheral aromatase site may be greater than 1,000 to 1. These considerations suggest that postmenopausal women may be especially sensitive to the effects of nic-1732 R. L. Barbieri, J. Gochberg, and K. J. Ryan ru a .0 n otine and cotinine on estrogen production. Jensen et al. have recently reported that in postmenopausal women, smoking may increase the metabolic clearance rate of estradiol (31) . To determine the relative quantitative effects of smoking on estrogen production versus metabolism will require sophisticated in vivo radiotracer studies.
